Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adavosertib with Chemotherapy in p53 Mutant Ovarian Cancer
NCT01357161Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jul 2011
- Primary completion
- Aug 2016
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of adavosertib in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Merck & Co.. Started Jul 2011; status: completed.
02
Drugs
adavosertib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT01357161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01357161.